Cellectis S.A.CLLSNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +10351.61% | +4393.64% | +135.31% | +107.48% | +117.11% |
| Gross Profit Growth | +0.00% | +8694.83% | +295.79% | +118.96% | +144.74% |
| EBITDA Growth | +0.00% | +0.00% | -196.13% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | -421.25% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | -329.01% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | -429.07% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +80.08% | +39.50% | +39.47% | +11.66% | +0.23% |
| Weighted Average Shares Diluted Growth | +80.08% | +39.50% | -2.85% | +11.66% | +0.23% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -100.12% | +0.00% | -119.76% | +0.00% |
| Free Cash Flow Growth | +0.00% | -104.54% | +0.00% | -120.76% | +0.00% |
| Receivables Growth | +6993.13% | -0.40% | -36.82% | +11.45% | -71.10% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +88.78% | +14.74% | +2.72% | -13.06% | -13.35% |
| Book Value per Share Growth | -5.59% | +10.90% | -8.01% | -41.48% | -22.54% |
| Debt Growth | +9.57% | +7.53% | -2.60% | +3.89% | -58.93% |
| R&D Expense Growth | +24.92% | -18.26% | -1.76% | -1.86% | +1.01% |
| SG&A Expenses Growth | -37.68% | -80.00% | -1.52% | -2.64% | +23.27% |